AACR: Targeting Luminal Breast Cancer Stem Cells With Trastuzumab Blocks Metastatic Growth in Preclinical Models

Trastuzumab (Herceptin) therapy may be useful for the treatment of luminal breast cancer stem cells, preventing them from growing into macrometastases, according to preclinical results presented at the 2013 American Association for Cancer Research Annual Meeting.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news